Ontology highlight
ABSTRACT:
SUBMITTER: Lecocq Q
PROVIDER: S-EPMC6831473 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Lecocq Quentin Q De Vlaeminck Yannick Y Hanssens Heleen H D'Huyvetter Matthias M Raes Geert G Goyvaerts Cleo C Keyaerts Marleen M Devoogdt Nick N Breckpot Karine K
Theranostics 20191015 25
Targeted therapy and immunotherapy have become mainstream in cancer treatment. However, only patient subsets benefit from these expensive therapies, and often responses are short-lived or coincide with side effects. A growing modality in precision oncology is the development of theranostics, as this enables patient selection, treatment and monitoring. In this approach, labeled compounds and an imaging technology are used to diagnose patients and select the best treatment option, whereas for ther ...[more]